Back

Reasons for replacement and extraction of the subcutaneous implantable cardioverter-defibrillator in a large cohort

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: ePosters Day 1 Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2022

About the speaker

Photo
Mrs Willeke van der Stuijt

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

128 More presentations in this session

Presentation thumbnail
Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping
Mr M. Van Schie (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Atrial high-rate episodes in patients with devices without a history of atrial fibrillation
Doctor I. Doundoulakis (Brussels, BE)
Abstract Slides
Presentation thumbnail
The impact of different fat depots in the body on the progression of atrial fibrillation - data from RACE V
Doctor V. Weberndoerfer (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures
Mr T. Kueffer (Bern, CH)
Abstract Slides
Presentation thumbnail
Early mortality and complications following first-time catheter ablation of atrial fibrillation in a nationwide cohort
Doctor C. Witt (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 1

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources